Chat with Filing

Ask questions about this document

Please log in or register to use the chat feature. Please register first.

RNS - Reports 2025 Second Quarter Financial Results

Company: Teva Pharmaceutical Industries Ltd. Date: 2025-07-30 Language: English Register to download

Loading document preview...

Document Preview Not Available

The file type (.htm) cannot be displayed directly here.

Open Original File

Error loading document preview. Please try the 'Open Original File' link.

You're One Click Away From The Full Filing

Instantly access this document—and 2.8M more—for free. Select your preferred method:

Continue with Google Continue with Microsoft Continue with Facebook Continue with Amazon

   

��� ����� �� ������ ������ ���� 2025 false

|     |     |
| --- | --- |
| ��� ������ ��������� ��"� | 2 380 |
| TEVA- PHARMACEUTICAL INDUSTRIES LTD |
| Corporation no: 520013954 | 13365 |
| - - - |
|     |

|     |     |     |     |     |     |     |     |     |     |     |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
|     | Israel Securities Authority |     |     | Tel Aviv Stock Exchange |     | C002 ( Public ) |     | Reported via MAGNA: | 30/07/2025 |     |
|     | www.isa.gov.il |     |     | www.tase.co.il |     |     |     | Reference: | 2025-02-056751 | Time of broadcast: 14:06 14:06 |

- - -

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000  

  

|     |     |
| --- | --- |
|     | The corporation is a foreign private issuer as defined by U.S. Securities Laws. |

  

Attached hereto is a report on*��� ����� �� ������ ������ ���� 2025*  

*Q2\_2025\_Press\_Release\_and\_tables\_and\_8K\_isa.pdf*

|     |     |
| --- | --- |
| *For an accessible version of this Press Release, please visit www.tevapharm.com* |     |
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): |     |
|     |     |
|     |     |
| - - - |     |
| Stock Exchange/Market: NYSE | Date of revision of form structure: 06/08/2024 |
| Address: Dvora Hanevi'a 124 , Tel Aviv 6944020   , Tel: 03-9148262 , Fax: 03-9267519 |     |
| E-mail address: Yael.Ashman@teva.co.il |     |
|     |     |
| Previous names of reporting entity: |     |
|     |     |
| Name of the Signatory: Kalif Eli Position of Signatory in the reporting corporation: Chief Financial Officer Name of Employer Company: |     |
| Address: Dvira Hanevia 124 , Tel Aviv 6944020 Telephone: 03-9148262 Facsimile: E-mail: yael.ashman@teva.co.il 1 |     |
|     |